Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blanca Ledezma

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oncology Nursing Forum|January 13, 2009
Ipilimumab for advanced melanoma: a nursing perspectiveBlanca Ledezma
Cancer Management and Research|January 1, 2014
Real-world impact of education: treating patients with ipilimumab in a community practice settingBlanca Ledezma, Annie Heng
Clinical Journal of Oncology Nursing|August 4, 2011
Atypical clinical response patterns to ipilimumabBlanca Ledezma, Sandra Binder, Omid Hamid
BMJ Case Reports|June 6, 2014
Metastatic human epidermal growth factor 2 (HER2/neu) amplified breast cancer with acute fulminant hepatitis responding to trastuzumab, pertuzumab and carboplatinMariela N Macias, Daniel Sanghoon Shin, Blanca Ledezma, et al.
The Oncologist|July 23, 2025
Datopotamab Deruxtecan-Associated Select Adverse Events: Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and ManagementAaron Lisberg, Laura A Huppert, Balazs Halmos, et al.
Patient Education and Counseling|April 11, 2025
Patient, care partner, and provider voice in treatment decision-making for non-small cell lung cancerLisa Dwyer Orr, Julie Vanderpoel, Pratyusha Vadagam, et al.
Current Medical Research and Opinion|November 6, 2025
Differences in treatment decision-making for non-small cell lung cancer among patients and physicians, by race and ethnicityLisa Dwyer Orr, Pratyusha Vadagam, Julie Vanderpoel, et al.
Cancer Immunology Research|February 1, 2018
Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single CenterAaron Lisberg, D Andrew Tucker, Jonathan W Goldman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncology Nursing Forum|January 13, 2009
Ipilimumab for advanced melanoma: a nursing perspectiveBlanca Ledezma
Cancer Management and Research|January 1, 2014
Real-world impact of education: treating patients with ipilimumab in a community practice settingBlanca Ledezma, Annie Heng
Clinical Journal of Oncology Nursing|August 4, 2011
Atypical clinical response patterns to ipilimumabBlanca Ledezma, Sandra Binder, Omid Hamid
BMJ Case Reports|June 6, 2014
Metastatic human epidermal growth factor 2 (HER2/neu) amplified breast cancer with acute fulminant hepatitis responding to trastuzumab, pertuzumab and carboplatinMariela N Macias, Daniel Sanghoon Shin, Blanca Ledezma, et al.
The Oncologist|July 23, 2025
Datopotamab Deruxtecan-Associated Select Adverse Events: Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and ManagementAaron Lisberg, Laura A Huppert, Balazs Halmos, et al.
Patient Education and Counseling|April 11, 2025
Patient, care partner, and provider voice in treatment decision-making for non-small cell lung cancerLisa Dwyer Orr, Julie Vanderpoel, Pratyusha Vadagam, et al.
Current Medical Research and Opinion|November 6, 2025
Differences in treatment decision-making for non-small cell lung cancer among patients and physicians, by race and ethnicityLisa Dwyer Orr, Pratyusha Vadagam, Julie Vanderpoel, et al.
Cancer Immunology Research|February 1, 2018
Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single CenterAaron Lisberg, D Andrew Tucker, Jonathan W Goldman, et al.
Pageof 1